---
title: "EYEBIOTECH LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/fdb70829-724c-5b23-a8a2-38eee153ab9d
json: https://whiteintel.dev/api/public/dossier/fdb70829-724c-5b23-a8a2-38eee153ab9d
identifier: oo:GB-COH-13503296
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# EYEBIOTECH LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-13503296`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/fdb70829-724c-5b23-a8a2-38eee153ab9d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/fdb70829-724c-5b23-a8a2-38eee153ab9d  

## Ownership & control

### Owners / controllers

- **Merck & Co., Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f010a508-2a0a-45b1-9556-f8375da8fb64
- **SV7 (IMF) GP LLP** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/16e817a2-f89d-588c-af3e-688abc68a625
- **SV7 (IMF) GP LLP** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/16e817a2-f89d-588c-af3e-688abc68a625

### UBO chain (walk to the ultimate owner)

A **14-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `13503296`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2021-07-09
- **Registered office:** 120 Moorgate, London, EC2M 6UR, England
- **SIC:** 72110

### Officers

- LUCAS, Benjamin Paul — director · British · appointed 2024-07-11
- O'SHAUGHNESSY, Peter James — director · British · appointed 2026-07-01
- ROGERS, Martin Ian — director · British · appointed 2024-07-11
- ADAMIS, Anthony Peter — director · American · appointed 2021-08-27 · resigned 2024-07-11
- AKKARAJU, Srinivas, Dr — director · American · appointed 2022-02-03 · resigned 2024-07-11
- BINGHAM, Catherine Elizabeth, Dame — director · British · appointed 2021-07-09 · resigned 2024-07-11
- CAN TEMUCIN, Ebru — director · Turkish · appointed 2024-07-11 · resigned 2026-07-01
- COSTINE, James Allister John — director · British · appointed 2021-07-09 · resigned 2022-02-03
- DAVITIAN, Bernard Thomas — director · French · appointed 2023-10-13 · resigned 2024-07-11
- GUYER, David R, Dr — director · American · appointed 2021-08-02 · resigned 2024-07-11
- HARRISON, Evelyn Melinda — director · American · appointed 2022-04-05 · resigned 2024-07-11
- ROSS, Michael Jay — director · American · appointed 2021-08-02 · resigned 2024-07-11
- WALLNOFER, Andreas, Dr — director · Swiss · appointed 2022-02-03 · resigned 2024-07-11

### Beneficial owners (Persons with Significant Control)

- [Merck & Co., Inc.](https://whiteintel.dev/entity/f010a508-2a0a-45b1-9556-f8375da8fb64) — 75–100% shares · corporate PSC · United States — since 2024-07-11
- [Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp](https://whiteintel.dev/entity/16e817a2-f89d-588c-af3e-688abc68a625) — 25–50% shares · corporate PSC · United Kingdom — ceased 2023-10-13
- [Sv7 (Imf) Gp Llp On Behalf Of Sv7 Impact Medicine Fund Lp](https://whiteintel.dev/entity/16e817a2-f89d-588c-af3e-688abc68a625) — 75–100% shares · corporate PSC · United Kingdom — ceased 2022-02-03

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/13503296
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/13503296

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **EYEBIOTECH LIMITED**. Human view: https://whiteintel.dev/entity/fdb70829-724c-5b23-a8a2-38eee153ab9d · Structured JSON: https://whiteintel.dev/api/public/dossier/fdb70829-724c-5b23-a8a2-38eee153ab9d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._